SCHEMBL8323157

SCHEMBL8323157

COCCNC(=O)c1cc(C)ccc1N

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 7/20 0.56
MAPK1 P28482 2/20 0.56
ALDH1A1 P00352 2/20 0.56
HSD17B10 Q99714 2/20 0.56
TP53 P04637 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
ALOX15 P16050 1/20 0.50
POLB P06746 1/20 0.49
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA3 P07451 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA13 Q8N1Q1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7005423 0.86 ALDH1A1 (0.46) HPGDMAPK1ALDH1A1HSD17B10TP53
SCHEMBL13634359 0.84 POLB (0.49) HPGDMAPK1ALDH1A1HSD17B10TP53
SCHEMBL13162820 0.82 HPGD (0.53) HPGDMAPK1ALDH1A1HSD17B10TP53
SCHEMBL12124297 0.82 MEN1 (0.56) HPGDMAPK1ALDH1A1SMN1; SMN2POLB
SCHEMBL25425226 0.81 MEN1 (0.57) HPGDMAPK1ALDH1A1ALOX15POLB
SCHEMBL13753816 0.81 HPGD (0.49) HPGDMAPK1ALDH1A1HSD17B10TP53
SCHEMBL2546081 0.80 ALDH1A1 (0.68) HPGDMAPK1ALDH1A1HSD17B10TP53
SCHEMBL30223440 0.80 ALDH1A1 (0.68) HPGDMAPK1ALDH1A1HSD17B10TP53
SCHEMBL22066864 0.78 LMNA (0.50) HPGDMAPK1ALDH1A1HSD17B10SMN1; SMN2
SCHEMBL31504981 0.77 HPGD (0.57) HPGDMAPK1ALDH1A1ALOX15CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0929533-A1 4,4-DISUBSTITUTED-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS AND INTERMEDIATES AND PROCESSES FOR MAKING THE SAME Du Pont Pharmaceuticals Company (US) 1999-07-21 EP disclosed
WO-1998014436-A1 4,4-DISUBSTITUTED-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONES USEFUL AS HIV REVERSE TRANSCRIPTASE INHIBITORS AND INTERMEDIATES AND PROCESSES FOR MAKING THE SAME DUPONT PHARMACEUTICALS COMPANY (US) 1998-04-09 WO disclosed